Literature DB >> 8827945

Mechanisms of alterations in cardiac membrane Ca2+ transport due to excess catecholamines.

K S Dhalla1, H Rupp, R E Beamish, N S Dhalla.   

Abstract

The occurrence of excessive catecholamine release is often associated with stress due to the lifestyle of Western societies. Contrary to the general thinking that excess catecholamines produce cardiotoxicity mainly via binding to adrenoceptors, there is increasing evidence that catecholamine-induced deleterious actions may also occur through oxidative mechanisms. In this overview it is shown that a high dose of isoproterenol induces a biphasic change in cardiac Ca2+ transport in the sarcolemma and in sarcoplasmic reticulum. Both sarcolemmal and sarcoplasmic reticular Ca2+-transport activities are initially increased to maintain Ca2+ homeostasis and then are impaired, which may be associated with the occurrence of intracellular Ca2+ overload. On the other hand, mitochondrial Ca2+-transport activities exhibited a delayed increase. Pretreatment with vitamin E partially prevented the deleterious changes in cardiac membranes as well as the depressed energetic status of the heart muscle cell. It is concluded that excess catecholamines affect Ca2+-transport mechanisms primarily via oxidation reactions involving free radical-mediated damage. Thus drug approaches that reduce circulating catecholamines and/or prevent their oxidation should prove beneficial. A combination therapy involving inhibitors of catecholamine release, blockers of adrenoceptors, and antioxidants may be indicated for stress-induced heart disease.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8827945     DOI: 10.1007/bf00120492

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  18 in total

1.  Cytolytic anticardiac membrane antibodies in the pathogenesis of myopericarditis.

Authors:  B Maisch; L Drude; C Hengstenberg; G Hufnagel; U Schönian; D Schwab
Journal:  Postgrad Med J       Date:  1992       Impact factor: 2.401

2.  Adrenochrome uptake and subcellular distribution in the isolated perfused rat heart.

Authors:  L Fliegel; S Takeo; R E Beamish; N S Dhalla
Journal:  Can J Cardiol       Date:  1985-03       Impact factor: 5.223

3.  Hemodynamic and neurohumoral effects of moxonidine in patients with essential hypertension.

Authors:  V Mitrovic; W Patyna; J Hüting; M Schlepper
Journal:  Cardiovasc Drugs Ther       Date:  1991-12       Impact factor: 3.727

4.  Excess catecholamines and the metabolic syndrome: should central imidazoline receptors be a therapeutic target?

Authors:  H Rupp; R Jacob
Journal:  Med Hypotheses       Date:  1995-03       Impact factor: 1.538

5.  Biphasic changes in the sarcolemmal phosphatidylethanolamine N-methylation activity in catecholamine-induced cardiomyopathy.

Authors:  K Okumura; V Panagia; R E Beamish; N S Dhalla
Journal:  J Mol Cell Cardiol       Date:  1987-04       Impact factor: 5.000

6.  Role of free radicals in catecholamine-induced cardiomyopathy.

Authors:  P K Singal; N Kapur; K S Dhillon; R E Beamish; N S Dhalla
Journal:  Can J Physiol Pharmacol       Date:  1982-11       Impact factor: 2.273

7.  Effect of adrenochrome on adenine nucleotides and mitochondrial oxidative phosphorylation in rat heart.

Authors:  G M Taam; S Takeo; A Ziegelhoffer; P K Singal; R E Beamish; N S Dhalla
Journal:  Can J Cardiol       Date:  1986 Mar-Apr       Impact factor: 5.223

8.  Potential oxidative pathways of catecholamines in the formation of lipid peroxides and genesis of heart disease.

Authors:  P K Singal; R E Beamish; N S Dhalla
Journal:  Adv Exp Med Biol       Date:  1983       Impact factor: 2.622

9.  Mechanisms of cardiac cell damage due to catecholamines: significance of drugs regulating central sympathetic outflow.

Authors:  H Rupp; K S Dhalla; N S Dhalla
Journal:  J Cardiovasc Pharmacol       Date:  1994       Impact factor: 3.105

10.  A novel mechanism of action for hypertension control: moxonidine as a selective I1-imidazoline agonist.

Authors:  P Ernsberger; M A Haxhiu; L M Graff; L A Collins; I Dreshaj; D L Grove; M E Graves; S G Schäfer; M O Christen
Journal:  Cardiovasc Drugs Ther       Date:  1994-03       Impact factor: 3.727

View more
  4 in total

1.  Biochemical effects of Solidago virgaurea extract on experimental cardiotoxicity.

Authors:  Walid Hamdy El-Tantawy
Journal:  J Physiol Biochem       Date:  2013-07-20       Impact factor: 4.158

2.  Effect of pretreatment with coenzyme Q10 on isoproterenol-induced cardiotoxicity and cardiac hypertrophy in rats.

Authors:  Arvindkumar E Ghule; Chetan P Kulkarni; Subhash L Bodhankar; Vijaya A Pandit
Journal:  Curr Ther Res Clin Exp       Date:  2009-12

3.  Cardioprotective effect of ritonavir, an antiviral drug, in isoproterenol induced myocardial necrosis: a new therapeutic implication.

Authors:  Prachi Gupta; Abhinav Kanwal; Uday Kumar Putcha; Yogesh Bulani; Bhavesh Sojitra; Tarak Nath Khatua; Madhusudana Kuncha; Sanjay Kumar Banerjee
Journal:  J Transl Med       Date:  2013-03-26       Impact factor: 5.531

4.  Aegle marmelos fruit extract attenuates isoproterenol-induced oxidative stress in rats.

Authors:  Gadham Setty Saayi Krushna; Mohammed Abdul Kareem; Vaddi Damodara Reddy; Pannuru Padmavathi; Shaik Althaf Hussain; Lakshmi Devi Kodidhela
Journal:  J Clin Biochem Nutr       Date:  2011-12-14       Impact factor: 3.114

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.